The main focus is on the plausible mechanisms by which torsinA and its activator LAP1 regulate hepatic lipid metabolism and NAFLD/NASH development (summarized in Figure 4). Here, TOR1AIP1 is linked to metabolic dysfunction-associated steatohepatitis.